As EMT is expected to be a more potent phenomenon when metastatic spread occurs, we speculate that our EpCAM-independent method allow us to capture CTCs from SCLC that would remain undetected using CellSearch® approach, especially in late-stage SCLC. This evidence concerns the gene EPCAM and small cell lung carcinoma.